Remus Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	369.9	290.7	205.2	85.03	34.34
Depreciation & Amortization	27.6	18.6	11	4.64	1.55
Other Amortization	-	0.1	0.2	0.13	-
Loss (Gain) From Sale of Assets	-0.2	-2.1	-	-	-
Loss (Gain) From Sale of Investments	2.9	-	-	-	-
Other Operating Activities	118.1	93.6	21.7	-3.93	-1.72
Change in Accounts Receivable	-318.1	72.6	-481.2	-19.33	6.89
Change in Inventory	-205	-84.4	-7.7	13.02	-4.39
Change in Accounts Payable	47.6	-224.1	390.2	-15.07	14.97
Change in Other Net Operating Assets	138.8	-95.2	-125.9	-11.36	-1.26
Operating Cash Flow	181.6	69.8	13.5	53.13	50.38
Operating Cash Flow Growth	160.17%	417.04%	-74.59%	5.46%	77.52%
Capital Expenditures	-145.7	-39.8	-32.9	-27.32	-0.71
Sale of Property, Plant & Equipment	8.8	3	-	-	-
Cash Acquisitions	-	-	-87.3	-	-
Investment in Securities	-188.6	2.7	32.6	-175.48	-30.01
Other Investing Activities	62.4	-42.5	-178.3	3.45	2.44
Investing Cash Flow	-150.3	-105.5	-301.1	-151.92	-45.45
Short-Term Debt Issued	-	89.3	-	-	-
Long-Term Debt Issued	41.9	3.3	23.5	77.51	-
Total Debt Issued	41.9	92.6	23.5	77.51	-
Short-Term Debt Repaid	-1.1	-	-6.4	-	-
Long-Term Debt Repaid	-	-5.1	-58.6	-	-0.87
Total Debt Repaid	-1.1	-5.1	-65	-	-0.87
Net Debt Issued (Repaid)	40.8	87.5	-41.5	77.51	-0.87
Issuance of Common Stock	-	-	467	42.5	-
Common Dividends Paid	-11.8	-11.8	-5.9	-	-
Other Financing Activities	-14.3	-15	-142.9	-2.33	-0.87
Financing Cash Flow	14.7	60.7	276.7	117.69	-1.74
Miscellaneous Cash Flow Adjustments	-0.1	0.1	48	0	-
Net Cash Flow	45.9	25.1	37.1	18.9	3.18
Free Cash Flow	35.9	30	-19.4	25.81	49.67
Free Cash Flow Growth	19.67%	-	-	-48.03%	79.21%
Free Cash Flow Margin	0.42%	0.48%	-0.91%	5.72%	20.09%
Free Cash Flow Per Share	3.80	2.55	-1.72	3.16	6.21
Cash Interest Paid	-	14.6	5	2.33	0.87
Cash Income Tax Paid	-	74.7	58.1	29.97	11.94
Levered Free Cash Flow	-177.98	-108.75	-394.05	7.45	42.87
Unlevered Free Cash Flow	-168.79	-99.63	-390.92	8.73	43.36
Change in Working Capital	-336.7	-331.1	-224.6	-32.74	16.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.